BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21871770)

  • 1. Client-Provider relationship in comprehensive substance abuse treatment: differences in residential and nonresidential settings.
    Shin HC; Marsh JC; Cao D; Andrews CM
    J Subst Abuse Treat; 2011 Dec; 41(4):335-46. PubMed ID: 21871770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effectiveness of residential versus outpatient aftercare for parolees from prison-based therapeutic community treatment programs.
    Burdon WM; Dang J; Prendergast ML; Messina NP; Farabee D
    Subst Abuse Treat Prev Policy; 2007 May; 2():16. PubMed ID: 17504540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance-based contracting within a state substance abuse treatment system: a preliminary exploration of differences in client access and client outcomes.
    Brucker DL; Stewart M
    J Behav Health Serv Res; 2011 Jul; 38(3):383-97. PubMed ID: 21249461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A descriptive survey of types, spread and characteristics of substance abuse treatment centers in Nigeria.
    Onifade PO; Somoye EB; Ogunwobi OO; Ogunwale A; Akinhanmi AO; Adamson TA
    Subst Abuse Treat Prev Policy; 2011 Sep; 6():25. PubMed ID: 21923946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transit and treatment: Aligning systems to address substance use in Connecticut.
    Cohen JP; Huleatt S; Murphy S; Rash CJ
    Health Serv Res; 2024 Feb; 59 Suppl 1(Suppl 1):e14268. PubMed ID: 38128579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis.
    Mojtabai R; Zivin JG
    Health Serv Res; 2003 Feb; 38(1 Pt 1):233-59. PubMed ID: 12650390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting satisfaction in outpatient substance abuse treatment: a prospective follow-up study.
    Kuusisto K; Lintonen T
    Subst Abuse Treat Prev Policy; 2020 May; 15(1):35. PubMed ID: 32448254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in comprehensive service availability in outpatient drug abuse treatment.
    Friedmann PD; Lemon SC; Durkin EM; D'Aunno TA
    J Subst Abuse Treat; 2003 Jan; 24(1):81-8. PubMed ID: 12646334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cultural competence in outpatient substance abuse treatment: measurement and relationship to wait time and retention.
    Guerrero E; Andrews CM
    Drug Alcohol Depend; 2011 Dec; 119(1-2):e13-22. PubMed ID: 21680111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance abuse intensive outpatient programs: assessing the evidence.
    McCarty D; Braude L; Lyman DR; Dougherty RH; Daniels AS; Ghose SS; Delphin-Rittmon ME
    Psychiatr Serv; 2014 Jun; 65(6):718-26. PubMed ID: 24445620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organizational correlates of service availability in outpatient substance abuse treatment programs.
    Edwards JR; Knight DK; Flynn PM
    J Behav Health Serv Res; 2011 Oct; 38(4):432-43. PubMed ID: 21107915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Program structure and counselor-client contact in outpatient substance abuse treatment.
    Knight DK; Broome KM; Simpson DD; Flynn PM
    Health Serv Res; 2008 Apr; 43(2):616-34. PubMed ID: 18370970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do resource dependencies affect treatment practices? The case of outpatient substance abuse treatment programs.
    Alexander JA; Wells R
    Med Care Res Rev; 2008 Dec; 65(6):729-47. PubMed ID: 18658141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding remote Aboriginal drug and alcohol residential rehabilitation clients: Who attends, who leaves and who stays?
    Munro A; Shakeshaft A; Breen C; Clare P; Allan J; Henderson N
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1(Suppl Suppl 1):S404-S414. PubMed ID: 29349855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving quality of care in substance abuse treatment using five key process improvement principles.
    Hoffman KA; Green CA; Ford JH; Wisdom JP; Gustafson DH; McCarty D
    J Behav Health Serv Res; 2012 Jul; 39(3):234-44. PubMed ID: 22282129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment needs of men and women with violence problems in substance use disorder treatment.
    Chermack ST; Murray RL; Winters JJ; Walton MA; Booth BM; Blow FC
    Subst Use Misuse; 2009; 44(9-10):1236-62. PubMed ID: 19938916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous quality improvement in substance abuse treatment facilities: How much does it cost?
    Hunt P; Hunter SB; Levan D
    J Subst Abuse Treat; 2017 Jun; 77():133-140. PubMed ID: 28189289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Availability and capacity of substance abuse programs in correctional settings: A classification and regression tree analysis.
    Taxman FS; Kitsantas P
    Drug Alcohol Depend; 2009 Aug; 103 Suppl 1(Suppl 1):S43-53. PubMed ID: 19395204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State and Service Estimates of Substance Use Treatment Facilities That Receive Public Funds in the United States.
    Ware OD
    Subst Abuse Rehabil; 2023; 14():173-182. PubMed ID: 38145058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary 6-month prospective study examining self-reported religious preference, religiosity/spirituality, and retention at a Jewish residential treatment center for substance-related disorders.
    Parhami I; Davtian M; Collard M; Lopez J; Fong TW
    J Behav Health Serv Res; 2014 Jul; 41(3):390-401. PubMed ID: 22460083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.